Neurofenix is an innovative digital therapeutics company empowering patients and their families to get their life back after suffering a stroke, traumatic brain injury or spinal cord injury. Our global team of highly motivated professionals includes bio-medical engineers, occupational therapists, software engineers and others. Many of us have personal experiences with neurological injuries, which inspire us in our day-to-day work. Neurofenix closed its Series A round of investment in August 2022, and is actively selling the NeuroBall platform to survivors, rehabilitation clinics and institutions for upper extremity recovery.